Navivumab Antibody
Navivumab (CT-P23) is a monoclonal antibody that neutralizes influenza A strains H1, H2, H5, and H9 by targeting the conserved HA2 stem domain. It is a valuable research tool for studying viral fusion mechanisms and has demonstrated neutralizing activity in both in vitro and in vivo preclinical studies.
Product Specifications
Target
Influenza Virus
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Infectious Disease & Virology
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
CP70051 1 L
Reagecon EDTA 0.05M Solution according to Chinese Pharmacopoeia (ChP)
Sign In for Pricing
View Details 